Drug and alcohol screening test mainly analyze biological samples such as urine, blood, and hair to diagnose the presence of the drug. The rise in alcohol consumption, overuse of prescribed drugs, the rise in usage of narcotics and illicit drugs are driving the global drug and alcohol screening market. The drug and alcohol screening market are projected to grow at a CAGR of 11.75% by the year 2024. The enforcement of strict laws and regulation in various countries and financial support from the government are the key growth factors of drug and alcohol screening market. Rise in alcohol and drug abuse, growing knowledge, and awareness among developing countries, growing aging population and competition among leading manufacturers in drug and alcohol screening market for innovative products are the reason for the increasing demand for drug and alcohol screening. Technological advancement is expected to boost the market over the world for the forecast period. The ban on alcohol and drug consumption in some countries and accuracy issues in testing instruments are hindering the growth of the market in the coming years.
In terms of geography, the global drug and alcohol screening market has been classified into North America, South America, Middle East, and Africa, Europe, and Asia-Pacific. Government policies towards drug usage are helping to grow more in North America. Asia-Pacific region is going to be a new hub for exporting dug screening instruments. Companies like, Alere Inc. has started its operation in India in 2016.
Key players operating in the global drug and alcohol screening market are Abbott, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd and OraSure Technologies, among others.
The drug and alcohol screening market has been analyzed through the following segments: